《现代医学与健康研究》编辑部官网!【中国医师协会系列期刊】
卡前列素氨丁三醇对高危剖宫产产妇产后出血与凝血功能的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R714.46+1

基金项目:


Effect of Carprost ambutritol on postpartum hemorrhage and coagulation function in high-risk cesarean section parturients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 研究卡前列素氨丁三醇对高危剖宫产产妇产后出血和凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)水平的影响。方法 将 2014 年 1 月至 2019 年 12 月丰顺县人民医院收治的 1 000 例高危剖宫产产妇,按照随机数字表法将其分为对照组与观察组,各 500 例。两组产妇均进行剖宫产手术,对照组产妇在胎儿娩出后予以缩宫素注射液治疗,观察组产妇在胎儿娩出后给予缩宫素注射液联合卡前列素氨丁三醇注射液治疗,两组产妇均产后观察 7 d。比较两组产妇用药前、用药 24 h 后心率、舒张压及收缩压,产后 2、24 h 出血量,恶露持续时间,产前、产后 24 h 的凝血功能指及产后不良反应发生情况。结 果 与用药前比,用药 24 h 后两组产妇心率升高,收缩压、舒张压降低,但两组间比较,差异均无统计学意义(均P > 0.05);与产后2 h 比,产后 24 h 两组产妇出血量均显著升高,而观察组显著低于对照组;观察组产妇恶露持续时间显著短于对照组;与产前比,产后24 h 两组产妇 PT、APTT、TT 均显著缩短,且观察组显著短于对照组;与产前比,产后 24 h 两组产妇 FIB 均显著降低,且观察组显著低于对照组(均P < 0.05);治疗期间两组产妇不良反应总发生率比较,差异无统计学意义(P > 0.05)。结论 卡前列素氨丁三醇可以有效改善高危剖宫产产妇术后凝血功能,减少高危剖宫产产妇产后出血量,预防产后大出血,同时可缩短恶露持续时间,对产妇生命体征无较大影响,且不增加不良反应,安全性良好。

    Abstract:

    Objective To research the effects of Carprost ambutritol on postpartum hemorrhage and prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (FIB) levels in high-risk cesarean section parturients. Methods A total of 1 000 cases high-risk cesarean parturients who were admitted to Fengshun County People's Hospital from January 2014 to December 2019 were divided into the control group and the observation group according to the random number table method, with 500 cases in each group. Parturients in both groups underwent cesarean section, parturients in the control group received Oxytocin injection after the foetus were delivered, and parturients in the observation group received Oxytocin injection and Carprost tromethamine after the foetus were delivered. Parturients in the both groups were observed for 7 days after delivery. The heart rate, diastolic blood pressure and systolic blood pressure of parturients before and 24 hours after medication, the blood loss 2 and 24 hours after delivery, the lochia duration, coagulation function and the occurrence of adverse reactions after delivery of parturients were compared between the two group. Results Compared with before medication, the heart rate of parturients decreased, the systolic blood pressure and diastolic blood pressure of parturients increased 24 hours after medication, but there was no significant difference between the two groups (all P > 0.05); compared with 2 hours after delivery, the bleeding volume of parturients in the two groups increased significantly 24 hours after delivery, and the observation group was significantly lower than the control group; the lochia duration of parturients in the observation group was significantly shorter than that in the control group; compared with the antenatal, the PT, APTT, and TT of parturients in the two groups shortened significantly 24 hours after delivery, and the observation group was significantly shorter than the control group; compared with the antenatal, the FIB of parturients in the two groups significantly decreased at 24 hours after delivery, and the observation group was significantly lower than the control group (all P <0.05); during treatment, there was no significant difference in the total incidence of adverse reactions between parturients in the two groups(P > 0.05). Conclusion Carprost tromethamine can effectively improve coagulation function, reduce the amount of postpartum hemorrhage of highrisk cesarean section parturients, and prevent the postpartum hemorrhage, at the same time, it can shorten the lochia duration and there is no significant effect on the vital signs of parturients without increasing the adverse effects, the safety is good.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-26
  • 出版日期:

地址:北京朝阳区北沙滩1号16信箱

邮编:100083

电话:010-64882183 64883630

E-mail:xdyx2020@vip.163.com


温馨提示:建议您使用Chrome80、火狐74+、IE11浏览器 ,当您的浏览器版本过低,可能会影响部分功能正常使用。

现代医学与健康研究 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司